Aclaris Therapeutics
ACRS
$1.19
Share price
0.00%
Change (1 day)
-85.80%
Change (1 year)
Categories
Aclaris Therapeutics (ACRS) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $40.22 M
According to Aclaris Therapeutics's latest financial reports the company's total liabilities are $40.22 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Aclaris Therapeutics - Total liabilities on balance sheet (from 2014 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $40.22 M | -29.4% |
| 2022-12-31 | $56.97 M | 5.76% |
| 2021-12-31 | $53.87 M | 62.58% |
| 2020-12-31 | $33.13 M | 16.73% |
| 2019-12-31 | $28.38 M | -53.04% |
| 2018-12-31 | $60.44 M | 231.24% |
| 2017-12-31 | $18.24 M | 176.68% |
| 2016-12-31 | $6.59 M | 324.12% |
| 2015-12-31 | $1.55 M | -95.92% |
| 2014-12-31 | $38.13 M | 63.17% |
| 2013-12-31 | $23.37 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -30.59% | 🇺🇸 USA |